Back to Search Start Over

Cost-Effectiveness of Azacitidine and Ivosidenib in Newly Diagnosed Older, Intensive Chemotherapy-Ineligible Patients with IDH1-Mutant Acute Myeloid Leukemia

Authors :
Bewersdorf, Jan Philipp
Patel, Kishan K
Goshua, George
Shallis, Rory Michael
Podoltsev, Nikolai A.
Stahl, Maximilian F.
Stempel, Jessica M.
Stein, Eytan
Huntington, Scott F.
Zeidan, Amer M.
Source :
Blood; November 2022, Vol. 140 Issue: 1, Number 1 Supplement 1 p319-321, 3p
Publication Year :
2022

Details

Language :
English
ISSN :
00064971 and 15280020
Volume :
140
Issue :
1, Number 1 Supplement 1
Database :
Supplemental Index
Journal :
Blood
Publication Type :
Periodical
Accession number :
ejs62732234
Full Text :
https://doi.org/10.1182/blood-2022-158465